Maternal and Child Health Practice Questions

Q: What is the definition of Maternal Mortality Rate?

None of the above. The correct answer is **None of the above** because the options provided confuse the definitions of Maternal Mortality Rate (MMR) and Maternal Mortality Ratio (MMR). ### 1. Understanding the Medical Concept In public health, there is a critical distinction between "Rate" and "Ratio": * **Maternal Mortality Ratio:** This is the most commonly used indicator. It is defined as the number of maternal deaths per **100,000 live births**. It measures the obstetric risk once a woman becomes pregnant. * **Maternal Mortality Rate:** This is defined as the number of maternal deaths in a given period per **1,000 women of reproductive age (15–49 years)**. It reflects both the risk of maternal death per pregnancy and the frequency with which women are exposed to that risk (fertility). ### 2. Why the other options are wrong * **Options A & C:** These use "births" (which includes stillbirths) as the denominator. Standard maternal mortality indicators typically use "live births" or the "female population of reproductive age." * **Option B:** This describes a proportion (per 100 live births), but the standard multiplier for the Maternal Mortality Ratio is **100,000**, not 100. ### 3. High-Yield NEET-PG Pearls * **Denominator Trap:** Always check if the question asks for *Ratio* (Denominator: Live Births) or *Rate* (Denominator: Women aged 15-49). * **Maternal Death Definition:** Death of a woman while pregnant or within **42 days** of termination of pregnancy, irrespective of the duration and site of the pregnancy. * **Most Common Cause:** In India, the leading cause of maternal mortality is **Obstetric Hemorrhage** (specifically Postpartum Hemorrhage/PPH). * **Current Target:** The Sustainable Development Goal (SDG) target 3.1 aims to reduce the global maternal mortality ratio to less than **70 per 100,000 live births** by 2030.

Q: What is the iron content of the MALA-D contraceptive?

19.5 mg. **Explanation:** Mala-D is a Combined Oral Contraceptive Pill (COCP) provided under the National Family Welfare Programme in India. Each cycle pack contains **28 tablets**: 21 hormonal (active) tablets and 7 non-hormonal (placebo) tablets. **1. Why 19.5 mg is correct:** The 7 brown-colored placebo tablets in the Mala-D pack are not empty; they contain **Ferrous Fumarate**. Each of these 7 tablets contains **60 mg of Ferrous Fumarate**, which provides exactly **19.5 mg of elemental iron**. This is included to maintain the habit of daily pill-taking and to supplement iron stores, as many women in the reproductive age group in India suffer from iron-deficiency anemia due to menstrual blood loss. **2. Analysis of Incorrect Options:** * **10 mg:** This is a distracter and does not correspond to standard iron formulations in OCPs. * **29.5 mg:** This is often confused with the elemental iron content of other supplements. * **40 mg:** While some therapeutic iron doses are higher, the standard prophylactic dose in Mala-D remains 19.5 mg elemental iron. **3. High-Yield Clinical Pearls for NEET-PG:** * **Composition of Active Pill:** 0.15 mg Levonorgestrel + 0.03 mg Ethinyl Estradiol. * **Mala-N vs. Mala-D:** Both have the same composition. The only difference is that **Mala-N is free** of cost at government centers, while **Mala-D is subsidized** (social marketing). * **Centchroman (Chhaya):** A non-steroidal, once-a-week pill (Selective Estrogen Receptor Modulator). * **Failure Rate:** The Pearl Index of COCPs with perfect use is 0.1 per 100 woman-years.

Q: Integrated Management of Childhood Illness (IMCI) guidelines include management of all the following conditions EXCEPT:

Tuberculosis (TB). ### Explanation The **Integrated Management of Childhood Illness (IMCI)** strategy, developed by WHO and UNICEF, is designed to reduce global child mortality by focusing on the most common causes of death in children under five years of age. **Why Tuberculosis (TB) is the Correct Answer:** IMCI focuses on the **syndromic management** of acute, life-threatening conditions that require immediate intervention at the primary health care level. While TB is a significant pediatric health issue, it is a **chronic infection** requiring specialized diagnostic tools (like gastric lavage or CBNAAT) and long-term treatment protocols under the National Tuberculosis Elimination Program (NTEP). Therefore, it is not included in the standard IMCI management algorithms for acute childhood illnesses. **Analysis of Incorrect Options:** * **Acute Respiratory Infections (ARI):** IMCI classifies ARI (specifically Pneumonia) based on respiratory rate and chest indrawing. It is a core component because it is a leading cause of child mortality. * **Malaria:** In endemic areas, IMCI includes protocols for assessing and treating fever, with specific algorithms for Malaria based on blood smears or RDTs. * **Diarrhea:** IMCI provides comprehensive guidelines for assessing dehydration levels and managing diarrhea using ORS and Zinc, as it is a major cause of preventable death. **High-Yield Clinical Pearls for NEET-PG:** * **Age Group:** IMCI covers two groups: **0–2 months** (Young Infants) and **2 months–5 years**. * **The "Big Five":** IMCI primarily targets **Pneumonia, Diarrhea, Malaria, Measles, and Malnutrition** (including Anemia). * **Color Coding:** IMCI uses a "Triage" system: **Pink** (Urgent referral), **Yellow** (OPD treatment), and **Green** (Home management). * **IMNCI (India):** In India, "Neonatal" was added (IMNCI) to include care for the first 0–28 days of life, emphasizing home-based newborn care.

Q: Maximum maternal mortality during the peripartum period occurs at which stage?

Immediate postpartum. **Explanation:** The **immediate postpartum period** (the first 24 to 48 hours after delivery) is the most critical window for maternal survival. The primary reason for this is **Postpartum Hemorrhage (PPH)**, which is the leading cause of maternal mortality worldwide and in India. During this stage, the sudden hemodynamic shift and the risk of uterine atony can lead to rapid, life-threatening blood loss. Additionally, conditions like amniotic fluid embolism and eclampsia-related complications frequently peak during or immediately after delivery. **Analysis of Options:** * **Last Trimester (A):** While risks like Pre-eclampsia and Antepartum Hemorrhage (APH) exist, they are generally manageable with timely intervention and rarely cause the volume of sudden deaths seen during delivery. * **During Labor (B):** Although labor is high-risk due to potential rupture or distress, the most fatal complications (like massive PPH) typically manifest immediately after the placenta is expelled. * **Delayed Postpartum (D):** This period (after 48 hours up to 42 days) carries risks like puerperal sepsis and secondary PPH, but these are usually slower in progression and less frequently fatal compared to the hyper-acute events of the first 24 hours. **High-Yield NEET-PG Pearls:** * **The "Big Three" causes of Maternal Mortality:** Hemorrhage (most common), Sepsis, and Hypertensive disorders. * **Timeframe:** Approximately 50-70% of maternal deaths occur in the postpartum period; of these, the majority occur within the first 24 hours. * **Public Health Strategy:** This is why "Active Management of the Third Stage of Labor" (AMTSL) and institutional deliveries are prioritized in programs like JSY and JSSK to reduce MMR.

Q: What is the ideal number of antenatal visits recommended?

4. The correct answer is **A (4)**. ### **Explanation** The "Ideal" number of antenatal visits is a frequently tested concept in NEET-PG, often leading to confusion between WHO and National guidelines. 1. **Why Option A is Correct:** According to the **WHO (Focussed Antenatal Care model)** and the **Ministry of Health and Family Welfare (MoHFW), India**, the minimum recommended number of antenatal visits for a healthy pregnant woman is **4**. These are scheduled as follows: * **1st Visit:** Within 12 weeks (Registration/First trimester). * **2nd Visit:** Between 14–26 weeks (Second trimester). * **3rd Visit:** Between 28–34 weeks (Third trimester). * **4th Visit:** Between 36 weeks and term. 2. **Why Other Options are Incorrect:** * **Option B (8):** In 2016, the WHO updated its "Antenatal Care Model" to recommend a minimum of **8 contacts** to reduce perinatal mortality. However, in the context of standard Indian guidelines and traditional NEET-PG questions, **4** remains the "ideal minimum" unless "WHO 2016 guidelines" are specifically mentioned. * **Options C & D:** These do not correspond to any standard global or national protocol for routine antenatal care. ### **High-Yield Clinical Pearls for NEET-PG** * **Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA):** Conducted on the **9th of every month** to ensure at least one check-up by a specialist. * **Weight Gain:** Average weight gain during pregnancy is **11 kg**. * **Tetanus Prophylaxis:** Two doses of Td (Tetanus-diphtheria) are given; the first at registration and the second 4 weeks later. If the woman was immunized within the last 3 years, only one **booster dose** is required. * **Iron-Folic Acid (IFA):** 100mg elemental iron and 500mcg folic acid for 180 days (starting from the second trimester).

Q: Which of the following does a natural membrane condom protect against?

Conception. **Explanation:** The correct answer is **Conception**. Natural membrane condoms (also known as "lambskin" condoms) are made from the intestinal cecum of lambs. While they are effective as a mechanical barrier against sperm, they possess microscopic pores (approximately 1.5 µm in diameter). These pores are small enough to block sperm (which are about 3 µm wide), thereby preventing **conception**, but they are large enough to allow the passage of much smaller viral pathogens. **Analysis of Options:** * **Option A (Correct):** They provide effective contraception by acting as a physical barrier to sperm. * **Option B (Incorrect):** They do **not** protect against STIs, particularly viral infections like HIV, Hepatitis B, and HSV. These viruses are significantly smaller (0.1 µm) than the pores in the natural membrane. * **Option C (Incorrect):** Since they fail to provide a barrier against viral STIs, this option is false. Only latex or synthetic (polyurethane/polyisoprene) condoms protect against both. * **Option D (Incorrect):** They are an FDA-approved method for pregnancy prevention. **High-Yield Clinical Pearls for NEET-PG:** * **Latex Condoms:** The "Gold Standard" for dual protection (conception + STIs). They are degraded by oil-based lubricants (use water-based only). * **Polyurethane Condoms:** Thinner and stronger than latex; compatible with oil-based lubricants; safe for patients with latex allergies. * **Failure Rate:** The typical use failure rate for male condoms is approximately **13-18%**, while the perfect use failure rate is **2%**. * **Nonoxynol-9:** A spermicide often added to condoms; however, it may increase the risk of HIV transmission by causing vaginal/rectal mucosal irritation.

Q: What is the elemental iron and folic acid content of the pediatric iron-folic acid tablet supplied under the RCH program?

20 mg iron & 100 mcg folic acid. The correct answer is **A: 20 mg iron & 100 mcg folic acid**. ### **Educational Explanation** **1. Why Option A is Correct:** Under the **Anemia Mukt Bharat (AMB)** strategy (formerly under the RCH program), the dosage for children aged **5–9 years** (primary school-age) is a pink-colored, sugar-coated tablet containing **20 mg of elemental iron** and **100 mcg of folic acid**. This is administered weekly throughout the year (52 weeks). The goal is to prevent nutritional anemia during a period of rapid growth and cognitive development. **2. Analysis of Incorrect Options:** * **Option B & C (40 mg Iron):** These dosages do not align with current national guidelines for the pediatric age group. However, 45 mg of elemental iron is the dosage used for infants (6–59 months) in liquid form (bi-weekly). * **Option D (60 mg Iron):** This is the adult dosage. Under AMB, **60 mg elemental iron and 500 mcg folic acid** is the standard dose for adolescents (10–19 years), pregnant women, and lactating mothers. ### **High-Yield Clinical Pearls for NEET-PG** * **Age-wise Prophylaxis (AMB Strategy):** * **6–59 months:** 20 mg Iron + 100 mcg FA (1 ml Syrup, bi-weekly). * **5–9 years:** 20 mg Iron + 100 mcg FA (Pink Tablet, weekly). * **10–19 years:** 60 mg Iron + 500 mcg FA (Blue Tablet, weekly). * **Pregnant/Lactating:** 60 mg Iron + 500 mcg FA (Red Tablet, daily for 180 days). * **Elemental Iron Calculation:** Remember that **Ferrous Sulfate** contains 20% elemental iron, while **Ferrous Fumarate** contains 33%. * **Deworming:** Always pair iron supplementation with **Albendazole** (400 mg) twice a year (National Deworming Day) for children >2 years to ensure maximum efficacy.

Q: Non-medicated Intrauterine Devices (IUDs) are called as?

1st generation IUDs. ### Explanation **Correct Option: A (1st generation IUDs)** Intrauterine devices are classified into generations based on their composition and mechanism of action. **1st generation IUDs** are **non-medicated, inert devices** typically made of polyethylene or other polymers. They act primarily by inducing a sterile inflammatory response (foreign body reaction) in the endometrium, which is spermicidal and prevents implantation. The most classic example is the **Lippes Loop**, which is S-shaped and contains barium sulfate for radiopacity. **Analysis of Incorrect Options:** * **B. 2nd generation IUDs:** These are **medicated devices containing copper** (e.g., Cu-T 200, Cu-T 380A, Multiload 250/375). The addition of copper increases contraceptive efficacy by enhancing the spermicidal effect. * **C. 3rd generation IUDs:** These are **hormone-releasing devices** (e.g., Progestasert, LNG-20/Mirena). They release levonorgestrel, which thickens cervical mucus and thins the endometrial lining. * **D. Multi-load devices:** These are specific types of 2nd generation copper IUDs characterized by flexible side arms that reduce the risk of expulsion. **High-Yield Clinical Pearls for NEET-PG:** * **Lippes Loop:** The most common 1st generation IUD; it is no longer the first line due to higher rates of bleeding and expulsion compared to newer generations. * **Cu-T 380A (ParaGard):** The current "Gold Standard" copper IUD; it is effective for **10 years**. * **Mirena (LNG-20):** The 3rd generation IUD of choice for **Menorrhagia** (DUB) and provides protection for **5 years**. * **Mechanism of Action:** All IUDs primarily act by preventing fertilization (pre-conceptive), not as abortifacients.

Q: During which period of pregnancy is iron and folic acid supplementation typically recommended?

Second trimester. **Explanation:** The correct answer is **B. Second trimester**. According to the National Iron Plus Initiative (NIPI) and the Anemia Mukt Bharat guidelines, iron and folic acid (IFA) supplementation is recommended to start from the **14th week of pregnancy** (after the first trimester is completed). **Why the Second Trimester?** 1. **Organogenesis:** During the first trimester, the fetus undergoes critical organ development. Avoiding iron supplements during this period prevents potential teratogenic risks and avoids aggravating the physiological nausea and vomiting (morning sickness) common in early pregnancy. 2. **Increased Demand:** The physiological demand for iron significantly rises in the second and third trimesters due to the expansion of maternal red cell mass and the rapid growth of the fetus and placenta. **Analysis of Incorrect Options:** * **A. First Trimester:** Supplementation is generally avoided here to prevent worsening of nausea. However, **Folic Acid (400 mcg)** is recommended *pre-conceptionally* and during the first trimester to prevent Neural Tube Defects (NTDs). * **C. Third Trimester:** While iron is continued through the third trimester, it is not the *starting* point. * **D. Puerperium:** Supplementation continues for 180 days postpartum to replenish stores, but the initiation occurs much earlier. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylactic Dose:** 100 mg elemental Iron + 500 mcg Folic Acid daily for **180 days** during pregnancy, followed by **180 days** postpartum. * **Therapeutic Dose:** If hemoglobin is <11 g/dL, the dose is doubled (two tablets daily). * **Intravenous Iron:** Ferric Carboxymaltose (FCM) is the preferred agent for moderate anemia (Hb 7–8.9 g/dL) after the first trimester. * **Counseling:** Advise patients to take iron with Vitamin C (citrus fruits) to enhance absorption and avoid tea/coffee/calcium within 2 hours of intake.

Question 1

What is the definition of Maternal Mortality Rate?

Accepted Answer

None of the above

Answer

Maternal death per 100 births

Answer

Maternal death per 100 live births

Answer

Maternal death per 1000 births

Question 2

What is the iron content of the MALA-D contraceptive?

Accepted Answer

19.5 mg

Answer

10 mg

Answer

29.5 mg

Answer

40 mg

Question 3

Integrated Management of Childhood Illness (IMCI) guidelines include management of all the following conditions EXCEPT:

Accepted Answer

Tuberculosis (TB)

Answer

Acute Respiratory Infections (ARI)

Answer

Malaria

Answer

Diarrhea

Question 4

Maximum maternal mortality during the peripartum period occurs at which stage?

Accepted Answer

Immediate postpartum

Answer

Last trimester

Answer

During labor

Answer

Delayed postpartum

Question 5

What is the ideal number of antenatal visits recommended?

Accepted Answer

4

Answer

8

Answer

6

Answer

10

Question 6

Which of the following does a natural membrane condom protect against?

Accepted Answer

Conception

Answer

Sexually Transmitted Infections (STIs)

Answer

Both conception and Sexually Transmitted Infections (STIs)

Answer

None of the above

Question 7

What is the elemental iron and folic acid content of the pediatric iron-folic acid tablet supplied under the RCH program?

Accepted Answer

20 mg iron & 100 mcg folic acid

Answer

40 mg iron & 100 mcg folic acid

Answer

40 mg iron & 50 mcg folic acid

Answer

60 mg iron & 100 mcg folic acid

Question 8

Non-medicated Intrauterine Devices (IUDs) are called as?

Accepted Answer

1st generation IUDs

Answer

2nd generation IUDs

Answer

3rd generation IUDs

Answer

Multi-load devices

Question 9

A woman has shortest menstrual cycles of 26 days and longest cycle of 31 days. Calculate her unsafe period using the Rhythm method?

Accepted Answer

21st of cycle to 24th of cycle

Answer

20th of cycle to 23rd of cycle

Answer

19th of cycle to 22nd of cycle

Answer

22nd of cycle to 25th of cycle

Question 10

During which period of pregnancy is iron and folic acid supplementation typically recommended?

Accepted Answer

Second trimester

Answer

First trimester

Answer

Third trimester

Answer

Puerperium

Maternal and Child Health — MCQs

Maternal and Child Health — MCQs

On this page

Practice by Chapter

Want unlimited practice?